Technology

TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.

The funds will be used to further invest in its product innovation, including its Polaris Safety Constellation Architecture, and to merge with or purchase other companies.

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials and commercialization of its BCI.

At Future of Health’s invitation-only event, former CDC Director Dr. Rochelle Walensky sat down with MobiHealthNews to discuss the potential and challenges of AI in healthcare.

PredicTx expands clinical trial from Australia to India and the Middle East while working towards TGA approval and CE marking.

The increase in adjusted gross margin was related to a rise in average selling price and a decrease in software amortization costs for the company's software development investments.

Innovaccer’s healthcare data unification and analytics will be combined with Tawuniya’s experience in health insurance and risk management.

Cheney said that the MedTech tax was a barrier to medical innovation.

Dr. Daniela Carvalho, pediatric otolaryngologist at Rady Children's Health in San Diego, shares insights on performing California's first pediatric Nucleus Nexa cochlear implant and what this means for the future of pediatric hearing care.

Founded by a former financial analyst, Sol aims to close research and care gaps for Asian women navigating menopause and midlife.